Literature DB >> 16650677

Fundus autofluorescence in patients with pseudoxanthoma elasticum.

Miki Sawa1, Michael D Ober, K Bailey Freund, Richard F Spaide.   

Abstract

PURPOSE: To evaluate the autofluorescence findings of patients with pseudoxanthoma elasticum, a disease resulting from a defect in a reputed transport protein encoded by the gene adenosine triphosphate-binding cassette subtype C number 6.
DESIGN: Observational case series.
METHODS: Color, red-free monochromatic, and autofluorescence photography and fluorescein angiography of patients with pseudoxanthoma elasticum seen in a referral practice were evaluated. MAIN OUTCOME MEASURES: Cataloging of the abnormalities as detected by autofluorescence photography.
RESULTS: The 8 subjects ranged in age from 26 to 60 years (mean, 55+/-12), and their best-corrected visual acuity ranged from 20/20 to 5/400 (mean, 20/50). Of the 16 eyes of the 8 patients, all had abnormalities typical of pseudoxanthoma elasticum, including angioid streaks in 14, peau d'orange in 4, and choroidal neovascularization in 11. Angioid streaks appeared as hypoautofluorescent fissures, sometimes showing expansion of the hypoautofluorescence suggestive of retinal pigment epithelium (RPE) absence or atrophy. Peau d'orange had a stippled appearance of autofluorescence, and drusen of the optic nerve appeared as hyperautofluorescent bodies. In addition to the expansion of RPE atrophy around angioid streaks, 3 additional configurations of RPE atrophy were recognized as RPE rips in 6 eyes, multilobular areas of atrophy in 9 eyes, and broad areas of poorly demarcated atrophy in 5 eyes. Some eyes had more than one manifestation of RPE atrophy, but the latter 3 types of atrophy occurred in eyes with, but not necessary contiguous to, concurrent choroidal neovascularization.
CONCLUSIONS: Autofluorescence photography demonstrated that patients with pseudoxanthoma elasticum have more widespread areas of RPE disturbance, particularly atrophy, than what is detectable by other means of ocular imaging, which suggests that the RPE disturbance may play a role in the pathogenesis of visual loss in patients with pseudoxanthoma elasticum.

Entities:  

Mesh:

Year:  2006        PMID: 16650677     DOI: 10.1016/j.ophtha.2006.01.037

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

Review 1.  Advances in the diagnosis and immunotherapy for ocular inflammatory disease.

Authors:  Steven Yeh; Lisa J Faia; Robert B Nussenblatt
Journal:  Semin Immunopathol       Date:  2008-03-05       Impact factor: 9.623

2.  Pattern dystrophy-like changes and coquille d'oeuf atrophy in elderly patients affected by pseudoxanthoma elasticum.

Authors:  Vittoria Murro; Dario Pasquale Mucciolo; Dario Giorgio; Andrea Sodi; Federica Boraldi; Daniela Quaglino; Gianni Virgili; Fabrizio Giansanti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-05-22       Impact factor: 3.117

3.  Complementary angiographic and autofluorescence findings in pseudoxanthoma elasticum.

Authors:  Thomas K M Lee; Farzin Forooghian; Catherine Cukras; Wai T Wong; Emily Y Chew; Catherine B Meyerle
Journal:  Int Ophthalmol       Date:  2008-10-15       Impact factor: 2.031

4.  Fundus autofluorescence of choroidal melanocytic lesions and the effect of treatment.

Authors:  Kaan Gündüz; Jose S Pulido; Sophie J Bakri; Luis Amselem; Elisabeth Petit-Fond; Thomas Link
Journal:  Trans Am Ophthalmol Soc       Date:  2007

5.  Non-vascular vision loss in pseudoxanthoma elasticum.

Authors:  Irena Tsui; Brian S Fuchs; Chai Lin Chou; Stanley Chang; Stephen H Tsang
Journal:  Doc Ophthalmol       Date:  2007-11-22       Impact factor: 2.379

6.  A Case Series of "Solitary Idiopathic Choroiditis" and Proposal of a Nomenclature Change to "Idiopathic Scleroma".

Authors:  Emma Duignan; Roderick O'Day; Thomas Moloney; Waheeda Rahman; Bertil Damato
Journal:  Ocul Oncol Pathol       Date:  2020-11-10

7.  An update on the ocular phenotype in patients with pseudoxanthoma elasticum.

Authors:  Martin Gliem; Julie De Zaeytijd; Robert P Finger; Frank G Holz; Bart P Leroy; Peter Charbel Issa
Journal:  Front Genet       Date:  2013-04-04       Impact factor: 4.599

8.  Angioid streaks, clinical course, complications, and current therapeutic management.

Authors:  Ilias Georgalas; Dimitris Papaconstantinou; Chrysanthi Koutsandrea; George Kalantzis; Dimitris Karagiannis; Gerasimos Georgopoulos; Ioannis Ladas
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

9.  Combined Administration of Preoperative Intravitreal and Intraoperative Subretinal Recombinant Tissue Plasminogen Activator in Acute Hemorrhagic Age-related Macular Degeneration.

Authors:  Khaled Helaiwa; Lina R Paez; Peter Szurman; Kai Januschowski
Journal:  Cureus       Date:  2020-03-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.